FQK11013
Dog
Mouse
IgG2a
Monoclonal
APC
Lymphoma
0.5 mg/ml
Please contact with the lab for this information.
FCM
Liquid
0.01M PBS, pH 7.4, 0.2% BSA, 0.05% Proclin 300.
Store at 4°C for 12 months. Protect from light. Do not freeze.
Mab231
A novel cross-validated machine learning based Alertix-Cancer Risk Index for early detection of canine malignancies., PMID:40351765
A novel cross-validated machine learning based Alertix-Cancer Risk Index for early detection of canine malignancies., PMID:40351765
A new treatment for canine B-cell lymphoma based on a recombinant single-domain antibody immunotoxin derived from Pseudomonas aeruginosa exotoxin A., PMID:40256602
A new treatment for canine B-cell lymphoma based on a recombinant single-domain antibody immunotoxin derived from Pseudomonas aeruginosa exotoxin A., PMID:40256602
Establishment of B4-100 and B4-C4, clonal canine multiple myeloma cell lines and their application in generating monoclonal antibody-producing fully canine hybridomas., PMID:40168847
Establishment of B4-100 and B4-C4, clonal canine multiple myeloma cell lines and their application in generating monoclonal antibody-producing fully canine hybridomas., PMID:40168847
Current Review of Monoclonal Antibody Therapeutics in Small Animal Medicine., PMID:40002954
Current Review of Monoclonal Antibody Therapeutics in Small Animal Medicine., PMID:40002954
Sequential transcriptome profiling: comparative analysis of normal and canine lymphoma preceding detailed T-cell and B-cell subtype comparison., PMID:39911484
Sequential transcriptome profiling: comparative analysis of normal and canine lymphoma preceding detailed T-cell and B-cell subtype comparison., PMID:39911484
Update on development of monoclonal antibodies for use in clinical flow cytometry and research in dogs., PMID:39910737
Update on development of monoclonal antibodies for use in clinical flow cytometry and research in dogs., PMID:39910737
Use of thymidine kinase 1 autoantibody, thymidine kinase antigen, extracellular protein kinase A autoantibody, and C-reactive protein for early detection of malignant tumors in dogs., PMID:39639774
Use of thymidine kinase 1 autoantibody, thymidine kinase antigen, extracellular protein kinase A autoantibody, and C-reactive protein for early detection of malignant tumors in dogs., PMID:39639774
Flow cytometric-based detection of CD80 is a useful diagnostic marker of acute myeloid leukemia in dogs., PMID:39224452
Flow cytometric-based detection of CD80 is a useful diagnostic marker of acute myeloid leukemia in dogs., PMID:39224452
Safety and biologic activity of a canine anti-CD20 monoclonal antibody in dogs with diffuse large B-cell lymphoma., PMID:38662527
Safety and biologic activity of a canine anti-CD20 monoclonal antibody in dogs with diffuse large B-cell lymphoma., PMID:38662527
Melan-A immunolabeling in canine extramedullary plasmacytomas., PMID:38642035
Melan-A immunolabeling in canine extramedullary plasmacytomas., PMID:38642035
Multiple myeloma in dogs: Use of the cell block technique as a new diagnostic tool., PMID:38240087
Multiple myeloma in dogs: Use of the cell block technique as a new diagnostic tool., PMID:38240087
Use of human intravenous immunoglobulin for the treatment of 12 dogs with newly diagnosed malignant disease and presumed secondary immune-mediated thrombocytopenia., PMID:38239177
Use of human intravenous immunoglobulin for the treatment of 12 dogs with newly diagnosed malignant disease and presumed secondary immune-mediated thrombocytopenia., PMID:38239177
PDL1 immunohistochemistry in canine neoplasms: Validation of commercial antibodies, standardization of evaluation, and scoring systems., PMID:37920996
PDL1 immunohistochemistry in canine neoplasms: Validation of commercial antibodies, standardization of evaluation, and scoring systems., PMID:37920996
An initial characterisation of the Unfolded Protein Response pathway in haematopoietic canine cancer cell lines - a necessary step for the future development of new therapies in dogs with neoplasia., PMID:37818142
An initial characterisation of the Unfolded Protein Response pathway in haematopoietic canine cancer cell lines - a necessary step for the future development of new therapies in dogs with neoplasia., PMID:37818142
A monoclonal antibody-based sandwich ELISA for measuring canine Thymidine kinase 1 protein and its role as biomarker in canine lymphoma., PMID:37808109
A monoclonal antibody-based sandwich ELISA for measuring canine Thymidine kinase 1 protein and its role as biomarker in canine lymphoma., PMID:37808109
Safety and clinical efficacy of an anti-PD-L1 antibody (c4G12) in dogs with advanced malignant tumours., PMID:37792729
Safety and clinical efficacy of an anti-PD-L1 antibody (c4G12) in dogs with advanced malignant tumours., PMID:37792729
Studying the DNA damage response pathway in hematopoietic canine cancer cell lines, a necessary step for finding targets to generate new therapies to treat cancer in dogs., PMID:37655260
Studying the DNA damage response pathway in hematopoietic canine cancer cell lines, a necessary step for finding targets to generate new therapies to treat cancer in dogs., PMID:37655260
Baseline tumor gene expression signatures correlate with chemoimmunotherapy treatment responsiveness in canine B cell lymphoma., PMID:37624862
Baseline tumor gene expression signatures correlate with chemoimmunotherapy treatment responsiveness in canine B cell lymphoma., PMID:37624862
Development and characterization of mouse anti-canine PD-L1 monoclonal antibodies and their expression in canine tumors by immunohistochemistry in vitro., PMID:37477617
Development and characterization of mouse anti-canine PD-L1 monoclonal antibodies and their expression in canine tumors by immunohistochemistry in vitro., PMID:37477617
Immunohistochemical evidence of NF-kB activation in canine lymphomas, histiocytic sarcomas, hemangiosarcomas, and mast cell tumors., PMID:37357953
Immunohistochemical evidence of NF-kB activation in canine lymphomas, histiocytic sarcomas, hemangiosarcomas, and mast cell tumors., PMID:37357953
A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models., PMID:37223101
A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models., PMID:37223101
Rabbit derived VL single-domains as promising scaffolds to generate antibody-drug conjugates., PMID:36964198
Rabbit derived VL single-domains as promising scaffolds to generate antibody-drug conjugates., PMID:36964198
Clinical utility of an immunoglobulin A-based serological panel for the diagnosis of chronic enteropathy in dogs., PMID:36708202
Clinical utility of an immunoglobulin A-based serological panel for the diagnosis of chronic enteropathy in dogs., PMID:36708202
Serum thymidine kinase 1 activity as a prognostic biomarker in dogs with chemotherapy-treated diffuse large B-cell lymphoma., PMID:36651594
Serum thymidine kinase 1 activity as a prognostic biomarker in dogs with chemotherapy-treated diffuse large B-cell lymphoma., PMID:36651594
Co-Expression of T- and B-Cell Markers in a Canine Intestinal Lymphoma: A Case Report., PMID:36552451
Co-Expression of T- and B-Cell Markers in a Canine Intestinal Lymphoma: A Case Report., PMID:36552451
Randomised trial evaluating chemotherapy alone or chemotherapy and a novel monoclonal antibody for canine T-cell lymphoma: A multicentre US study., PMID:36329876
Randomised trial evaluating chemotherapy alone or chemotherapy and a novel monoclonal antibody for canine T-cell lymphoma: A multicentre US study., PMID:36329876
A clonality assay in canine B cell tumors targeting the immunoglobulin light chain lambda locus., PMID:36191469
A clonality assay in canine B cell tumors targeting the immunoglobulin light chain lambda locus., PMID:36191469
Implication of Netrin-1 Gain of Expression in Canine Nodal Lymphoma., PMID:36136711
Implication of Netrin-1 Gain of Expression in Canine Nodal Lymphoma., PMID:36136711
MHCII Expression on Peripheral Blood Monocytes in Canine Lymphoma: An Impact of Glucocorticoids., PMID:36009726
MHCII Expression on Peripheral Blood Monocytes in Canine Lymphoma: An Impact of Glucocorticoids., PMID:36009726
Development and application of a next-generation sequencing protocol and bioinformatics pipeline for the comprehensive analysis of the canine immunoglobulin repertoire., PMID:35802654
Development and application of a next-generation sequencing protocol and bioinformatics pipeline for the comprehensive analysis of the canine immunoglobulin repertoire., PMID:35802654
Evaluation of PEG-L-asparaginase in asparagine suppression and anti-drug antibody development in healthy Beagle dogs: A multi-phase preclinical study., PMID:35781075
Evaluation of PEG-L-asparaginase in asparagine suppression and anti-drug antibody development in healthy Beagle dogs: A multi-phase preclinical study., PMID:35781075
Microscopic detection of Leptospira bacterial organisms in urine sediment from a young dog with leptospirosis and a review of the pathobiology and diagnosis of canine leptospirosis., PMID:35619239
Microscopic detection of Leptospira bacterial organisms in urine sediment from a young dog with leptospirosis and a review of the pathobiology and diagnosis of canine leptospirosis., PMID:35619239
Using digital RNA counting to establish flow cytometry diagnostic criteria for subtypes of CD34+ canine acute leukaemia., PMID:35491468
Using digital RNA counting to establish flow cytometry diagnostic criteria for subtypes of CD34+ canine acute leukaemia., PMID:35491468
Urinary bladder wall mass with neoplastic lymphoid cells in the urine: Diagnosis of an IgG secretory B-cell lymphoma with Bence-Jones proteinuria in a dog., PMID:35488188
Urinary bladder wall mass with neoplastic lymphoid cells in the urine: Diagnosis of an IgG secretory B-cell lymphoma with Bence-Jones proteinuria in a dog., PMID:35488188
Serum TK1 protein and C-reactive protein correlate to treatment response and predict survival in dogs with hematologic malignancies., PMID:35245727
Serum TK1 protein and C-reactive protein correlate to treatment response and predict survival in dogs with hematologic malignancies., PMID:35245727
Characterization of the canine CD20 as a therapeutic target for comparative passive immunotherapy., PMID:35177658
Characterization of the canine CD20 as a therapeutic target for comparative passive immunotherapy., PMID:35177658
Expression and functional analysis of chemokine receptor 7 in canine lymphoma cell lines., PMID:34866095
Expression and functional analysis of chemokine receptor 7 in canine lymphoma cell lines., PMID:34866095
Lokivetmab improved pruritus in a dog with cutaneous epitheliotropic lymphoma., PMID:34866072
Lokivetmab improved pruritus in a dog with cutaneous epitheliotropic lymphoma., PMID:34866072
T-cell lymphoma-associated hemophagocytic syndrome in an American Pit Bull Terrier., PMID:34802304
T-cell lymphoma-associated hemophagocytic syndrome in an American Pit Bull Terrier., PMID:34802304
Mismatch repair deficiency in canine neoplasms., PMID:34538134
Mismatch repair deficiency in canine neoplasms., PMID:34538134
Immunohistochemical Characterization of Tumor-Associated Macrophages in Canine Lymphomas., PMID:34438760
Immunohistochemical Characterization of Tumor-Associated Macrophages in Canine Lymphomas., PMID:34438760
Development of a monoclonal antibody for the detection of anti-canine CD20 chimeric antigen receptor expression on canine CD20 chimeric antigen receptor-transduced T cells., PMID:34408098
Development of a monoclonal antibody for the detection of anti-canine CD20 chimeric antigen receptor expression on canine CD20 chimeric antigen receptor-transduced T cells., PMID:34408098
Diagnostic performance of routine electrophoresis and immunofixation for the detection of immunoglobulin paraproteins (M-Proteins) in dogs with multiple myeloma and related disorders: Part 1 - Current performance., PMID:33847384
Diagnostic performance of routine electrophoresis and immunofixation for the detection of immunoglobulin paraproteins (M-Proteins) in dogs with multiple myeloma and related disorders: Part 1 - Current performance., PMID:33847384
A rapid multiple immunofluorescence method for the simultaneous detection of CD20 and CD3 in canine and feline cytological samples., PMID:33814519
A rapid multiple immunofluorescence method for the simultaneous detection of CD20 and CD3 in canine and feline cytological samples., PMID:33814519
Hydrogen deuterium exchange mass spectrometry identifies the dominant paratope in CD20 antigen binding to the NCD1.2 monoclonal antibody., PMID:33284343
Hydrogen deuterium exchange mass spectrometry identifies the dominant paratope in CD20 antigen binding to the NCD1.2 monoclonal antibody., PMID:33284343
Evaluation of the performance of a human D-dimer test in dogs with neoplasia., PMID:33151164
Evaluation of the performance of a human D-dimer test in dogs with neoplasia., PMID:33151164
CD3-CD20-positive nodal lymphoma with cross-lineage rearrangement in a dog., PMID:33000710
CD3-CD20-positive nodal lymphoma with cross-lineage rearrangement in a dog., PMID:33000710
Establishment and Characterization of Monoclonal Antibody Against Canine CD8 Alpha., PMID:32822285
Establishment and Characterization of Monoclonal Antibody Against Canine CD8 Alpha., PMID:32822285
Generation of a canine anti-canine CD20 antibody for canine lymphoma treatment., PMID:32651429
Generation of a canine anti-canine CD20 antibody for canine lymphoma treatment., PMID:32651429
Study of DNA topoisomerase IIa expression in canine lymphomas and its potential role as a marker of sensitivity to anthracycline-based chemotherapy in dogs., PMID:32176312
Study of DNA topoisomerase IIa expression in canine lymphomas and its potential role as a marker of sensitivity to anthracycline-based chemotherapy in dogs., PMID:32176312
Order: order@antibodysystem.com
Mail: support@antibodysystem.com
For research use only. Not for human or drug use.
Find out more about placing an order here
